# Matão Controlling Hypertension (MatCH Study): Rationale and Design

> **NCT03147092** · EARLY_PHASE1 · UNKNOWN · sponsor: **Centro Neurológico de Pesquisa e Reabiitação, Brazil** · enrollment: 15000 (estimated)

## Conditions studied

- Hypertension
- Blood Pressure

## Interventions

- **DRUG:** Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,
- **DRUG:** Atenolol
- **DRUG:** Losartan potassium 50mg
- **DRUG:** Clonidine

## Key facts

- **NCT ID:** NCT03147092
- **Lead sponsor:** Centro Neurológico de Pesquisa e Reabiitação, Brazil
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2017-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03147092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03147092, "Matão Controlling Hypertension (MatCH Study): Rationale and Design". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03147092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*